Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease

about

Light chain deposition disease: novel biological insights and treatment advances.Long-term renal survival of γ3-heavy chain deposition disease: a case report.

P2860

Q37999472-261BEF22-96E2-4BE8-BBF6-D53905938818 Q41031071-C71533A1-8135-40B7-961B-D8581E56CF77

P2860

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease

Item

http://www.wikidata.org/entity/Q57904003

description

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 09 January 2012

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2012

@uk

name

Long-term follow-up after auto ...... heavy-chain deposition disease

@en

Long-term follow-up after auto ...... heavy-chain deposition disease

@nl

type

Item

label

Long-term follow-up after auto ...... heavy-chain deposition disease

@en

Long-term follow-up after auto ...... heavy-chain deposition disease

@nl

prefLabel

Long-term follow-up after auto ...... heavy-chain deposition disease

@en

Long-term follow-up after auto ...... heavy-chain deposition disease

@nl

P1476

Long-term follow-up after auto ...... heavy-chain deposition disease

@en

P2093

A Petrucci

http://www.w3.org/2001/XMLSchema#string

B A Zannetti

http://www.w3.org/2001/XMLSchema#string

E Zamagni

http://www.w3.org/2001/XMLSchema#string

L Pantani

http://www.w3.org/2001/XMLSchema#string

M Baccarani

http://www.w3.org/2001/XMLSchema#string

P Tacchetti

http://www.w3.org/2001/XMLSchema#string

P Tosi

http://www.w3.org/2001/XMLSchema#string

S Pasquali

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of light chain deposition disease with bortezomib and dexamethasone

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

Liver transplantation for liver rupture due to light chain deposition disease: a case report.

Long-term outcome of autologous stem cell transplantation in light chain deposition disease.

High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.

Infiltrative nonamyloidotic monoclonal immunoglobulin light chain cardiomyopathy: an underappreciated manifestation of plasma cell dyscrasias.

P2888

bmt.2011.252

P304

1248-1249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2011.252

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giulia Perrone

Michele Cavo

Annamaria Brioli

P577

2012-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22231462

http://www.w3.org/2001/XMLSchema#string

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease

about

P2860

P2860

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698